News Focus
News Focus
Followers 6
Posts 560
Boards Moderated 0
Alias Born 03/13/2007

Re: DewDiligence post# 3932

Tuesday, 06/26/2007 1:07:24 AM

Tuesday, June 26, 2007 1:07:24 AM

Post# of 19309
In any case, the main point is that $240M per year is not a trivial revenue stream for an FoB maker to pursue—provided that the FoB is substitutable for the original drug and doesn’t have to be actively marketed.


Point taken.

micro

Life is an IQ test.

email: microcapfun@yahoo.com

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now